Precipio, Inc. (NASDAQ:PRPO) Short Interest Down 15.6% in December

Precipio, Inc. (NASDAQ:PRPO) was the recipient of a significant drop in short interest in December. As of December 31st, there was short interest totalling 2,700 shares, a drop of 15.6% from the December 15th total of 3,200 shares. Approximately 0.2% of the company’s stock are short sold. Based on an average trading volume of 7,100 shares, the days-to-cover ratio is currently 0.4 days.

Precipio Stock Up 5.9 %

Precipio stock traded up $0.36 during trading hours on Friday, hitting $6.51. The stock had a trading volume of 10,823 shares, compared to its average volume of 7,864. The stock’s 50-day moving average price is $5.86 and its 200-day moving average price is $5.94. The stock has a market capitalization of $9.63 million, a P/E ratio of -3.56 and a beta of 1.41. Precipio has a 12-month low of $4.31 and a 12-month high of $7.30. The company has a quick ratio of 0.60, a current ratio of 0.73 and a debt-to-equity ratio of 0.02.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.